{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:36:23Z","timestamp":1774434983362,"version":"3.50.1"},"reference-count":18,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.3960\/jslrt.20003","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T22:04:50Z","timestamp":1589321090000},"page":"55-59","source":"Crossref","is-referenced-by-count":5,"title":["A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation"],"prefix":"10.3960","volume":"60","author":[{"given":"Noriko","family":"Iwaki","sequence":"first","affiliation":[{"name":"Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Mochizuki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Maeda","sequence":"additional","affiliation":[{"name":"Division of Diagnostic Pathology, Toyama Red Cross Hospital, Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kurokawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toyama Red Cross Hospital, Toyama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Vose J, Armitage J, Weisenburger D. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26: 4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Farcet JP, Gaulard P, Marolleau JP et al.<\/i> Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990; 75: 2213-2219.","DOI":"10.1182\/blood.V75.11.2213.2213"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Cooke CB, Krenacs L, Stetler-Stevenson M et al.<\/i> Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood. 1996; 88: 4265-4274.","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Belhadj K, Reyes F, Farcet JP et al.<\/i> Hepatosplenic T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients. Blood. 2003; 102: 4261-4269.","DOI":"10.1182\/blood-2003-05-1675"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Catania G, Zallio F, Monaco F et al.<\/i> Successful HLA haploidentical myeloablative stem cell transplantation for aggressive hepatosplenic alpha\/beta (\u03b1\u03b2) T-cell lymphoma. Leuk Res Rep. 2014; 3: 90-93.","DOI":"10.1016\/j.lrr.2014.09.001"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Travert M, Huang Y, de Leval L et al.<\/i> Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets. Blood. 2012; 119: 5795-5806.","DOI":"10.1182\/blood-2011-12-396150"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 McKinney M, Moffitt AB, Gaulard P et al.<\/i> The genetic basis of hepatosplenic T-cell lymphoma. Cancer Discov. 2017; 7: 369-379.","DOI":"10.1158\/2159-8290.CD-16-0330"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Tanase A, Schmitz N, Stein H et al.<\/i>. Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party. Leukemia. 2015; 29: 686-688.","DOI":"10.1038\/leu.2014.280"},{"key":"9","unstructured":"9 Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res. 1971; 31: 1860-1861."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Ansell SM, Habermann TM, Kurtin PJ et al.<\/i> Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol. 1997; 15: 2296-2301.","DOI":"10.1200\/JCO.1997.15.6.2296"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Gallamini A, Stelitano C, Calvi R et al.<\/i>. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004; 103: 2474-2479.","DOI":"10.1182\/blood-2003-09-3080"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Sorror ML, Maris MB, Storb R et al.<\/i> Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005; 106: 2912-2919.","DOI":"10.1182\/blood-2005-05-2004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Kurokawa T, Ishiyama K, Ozaki J et al.<\/i> Haploidentical hematopoietic stem cell transplantation to adults with hematologic malignancies: analysis of 66 cases at a single Japanese center. Int J Hematol. 2010; 91: 661-669.","DOI":"10.1007\/s12185-010-0561-5"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Yabe M, Medeiros LJ, Tang G et al.<\/i> Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol. 2016; 40: 676-688.","DOI":"10.1097\/PAS.0000000000000614"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Voss MH, Lunning MA, Maragulia JC et al.<\/i> Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk. 2013; 13: 8-14.","DOI":"10.1016\/j.clml.2012.09.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Le Gouill S, Milpied N, Buzyn A et al.<\/i>. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Soci\u00e9t\u00e9 Francaise de Greffe de Mo\u00eblle et de Th\u00e9rapie Cellulaire. J Clin Oncol. 2008; 26: 2264-2271.","DOI":"10.1200\/JCO.2007.14.1366"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Mart\u00ednez C, Gayoso J, Canals C et al.<\/i>. Post-transplantation cyclophosphamide-based haploidentical transplantation as alternative to matched sibling or unrelated donor transplantation for Hodgkin lymphoma: A registry study of the lymphoma working party of the European Society for Blood and Marrow Transplantation. J Clin Oncol. 2017; 35: 3425-3432.","DOI":"10.1200\/JCO.2017.72.6869"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ikegame K, Yoshida T, Yoshihara S et al.<\/i> Unmanipulated haploidentical reduced-intensity stem cell transplantation using fludarabine, busulfan, low-dose antithymocyte globulin, and steroids for patients in non-complete remission or at high risk of relapse: A prospective multicenter phase I\/II study in Japan. Biol Blood Marrow Transplant. 2015; 21: 1495-1505.","DOI":"10.1016\/j.bbmt.2015.04.012"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/2\/60_20003\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T04:28:22Z","timestamp":1592627302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/60\/2\/60_20003\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.20003","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}